ENTITY
Scilex

Scilex (SCLX US)

12
Analysis
Health Care • United States
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido® for postherpetic neuralgia, ELYXYB® for migraine, and GLOPERBA® for gout flares. The company is headquartered in Palo Alto, California, and was founded in 2019.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x